Mirataz 20mg/ml Transdermal Ointment for Cats 5g

Mirataz 20mg/ml Transdermal Ointment

The active ingredient Mirtazapine is absorbed through the skin of the ear into the bloodstream.

The effects of mirtazapine on weight gain are complex and not fully understood. They include blocking some of the actions of serotonin and histamine, substances involved in the regulation of appetite, and an effect on levels of leptin, a hormone that controls hunger.

Use this product as directed by your veterinary surgeon.

You should carefully read all product packaging and labels prior to use.

Do not use in breeding, pregnant or lactating cats.

Do not use in animals less than 7.5 months of age or less than 2 kg body weight.

Do not use in cases of hypersensitivity to the active substance or to any of the excipients.

Do not use in cats treated with cyproheptadine, tramadol or monoamine oxidase inhibitors (MAOIs) or treated with an MAOI within 14 days prior to treatment with the veterinary medicinal product as there may be an increased risk of serotonin syndrome.

Special precautions for use in animals:

• The veterinary medicinal product should not be applied on damaged skin.
• In the case of hepatic disease, elevated hepatic enzyme levels may be observed. Kidney disease may cause reduced clearance of mirtazapine, which may result in higher drug exposure. In these special cases, biochemical hepatic and renal parameters should be regularly monitored during the treatment.
• The effects of mirtazapine on glucose regulation have not been evaluated. In the case of use in cats with diabetes mellitus, glycaemia should be regularly monitored.
• When used in hypovolemic cats, supportive treatment (fluid therapy) should be implemented.
• Care should be taken that other animals in the household do not come in contact with the application site until it is dry.

Special precautions to be taken by the person administering the veterinary medicinal product to animals:

• Avoid direct contact with the product. Avoid contact with the treated animal for the first 12 hours after each daily application and until the application site is dry.
• Impermeable disposable protective gloves must be worn when handling and administering the veterinary medicinal product.
• Thoroughly wash hands immediately after administration of the veterinary medicinal product or in case of skin contact with the product or the treated cat.
• Do not leave the tube out of its child resistant container except during the application phase. Children must not be present when applying the treatment to the cat.

Shelf life after first opening the immediate packaging: 30 days